Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
phaseolus vulgaris lectin
- Development stage
- Unknown
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral, Subcutaneous
01
Overview
Phaseolus vulgaris lectin is a carbohydrate-binding protein found in common beans such as kidney beans. It exists mainly as erythroagglutinin(PHE-E) or leucoagglutinin(PHE-L). These proteins bind specific sugar residues on cell surfaces causing agglomeration(erythrocytes/leukocytes). They have both harmful effects(raw ingestion causes intestinal disorders)and possible health benefits(anti-cancer/anti-HIV/antimicrobial activities). Used mainly in biomedical research.
- Other names
- 芸豆凝集素 (Chinese)PhytohemagglutininPhaseolus vulgaris agglutinin
02
Targets
N-glycan (Complex-type N-glycan)
Beyond the preview
Go deeper on phaseolus vulgaris lectin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on phaseolus vulgaris lectin.